Biotalys NV Statistics

Total Valuation

Biotalys NV has a market cap or net worth of EUR 170.71 million. The enterprise value is 157.18 million.

Market Cap	170.71M
Enterprise Value	157.18M

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Biotalys NV has 37.52 million shares outstanding. The number of shares has increased by 11.78% in one year.

Current Share Class	37.52M
Shares Outstanding	37.52M
Shares Change (YoY)	+11.78%
Shares Change (QoQ)	+9.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.51%
Float	13.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.62
P/TBV Ratio	8.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.78

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.22.

Current Ratio	3.61
Quick Ratio	3.47
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-71.32

Financial Efficiency

Return on equity (ROE) is -75.33% and return on invested capital (ROIC) is -38.26%.

Return on Equity (ROE)	-75.33%
Return on Assets (ROA)	-32.17%
Return on Invested Capital (ROIC)	-38.26%
Return on Capital Employed (ROCE)	-63.52%
Revenue Per Employee	n/a
Profits Per Employee	-235,460
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biotalys NV has paid 24,000 in taxes.

Income Tax	24,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.37% in the last 52 weeks. The beta is 0.95, so Biotalys NV's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+48.37%
50-Day Moving Average	4.63
200-Day Moving Average	4.16
Relative Strength Index (RSI)	44.52
Average Volume (20 Days)	79,969

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.05M
Pretax Income	-14.81M
Net Income	-14.83M
EBITDA	-13.97M
EBIT	-15.05M
Earnings Per Share (EPS)	-0.42

Full Income Statement

Balance Sheet

The company has 17.82 million in cash and 4.29 million in debt, giving a net cash position of 13.53 million or 0.36 per share.

Cash & Cash Equivalents	17.82M
Total Debt	4.29M
Net Cash	13.53M
Net Cash Per Share	0.36
Equity (Book Value)	19.81M
Book Value Per Share	0.53
Working Capital	13.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.22 million and capital expenditures -80,000, giving a free cash flow of -12.30 million.

Operating Cash Flow	-12.22M
Capital Expenditures	-80,000
Free Cash Flow	-12.30M
FCF Per Share	-0.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biotalys NV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.78%
Shareholder Yield	-11.78%
Earnings Yield	-8.69%
FCF Yield	-7.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2